Conduction System Pacing Upgrade in Chronic Heart Failure with Severe Left Ventricular Dysfunction and Chronic Atrial

Yasumasa Nohno1, Katsuhito Fujiu2, Ryosuke Kozu1

  • 1Department of Cardiology, Saku Central Hospital Advanced Care Center.

PubMed

Insights

Cardiac resynchronization therapy (CRT) is a treatment for heart failure, but some patients don't respond. Conduction system pacing (CSP) offers an alternative, improving CRT effectiveness by using His-bundle pacing (HBP) or left bundle branch area pacing (LBBAP).

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Cardiac resynchronization therapy (CRT) is a standard treatment for severe congestive heart failure.
  • Approximately one-third of patients undergoing CRT do not respond to the therapy.
  • Conduction system pacing (CSP), encompassing His-bundle pacing (HBP) and left bundle branch area pacing (LBBAP), has emerged as a promising alternative and adjunct to CRT.

Purpose of the Study:

  • To describe a novel approach for upgrading patients to CRT with CSP.
  • To present a case series demonstrating the feasibility of utilizing atrial ports for HBP and LBBAP leads during CRT upgrades.
  • To evaluate the efficacy and simplicity of this combined CRT and CSP strategy.

Main Methods:

  • Two cases of patients with end-stage heart failure were upgraded to CRT with CSP.
  • HBP and LBBAP leads were implanted and connected to the atrial ports of an implantable cardiac defibrillator/CRT-defibrillator.
  • The procedure involved utilizing existing atrial ports for the novel pacing leads.

Main Results:

  • The implantation of HBP and LBBAP leads into atrial ports was technically successful in both cases.
  • The upgraded CRT with CSP therapy was deemed a simple, reasonable, and effective treatment.
  • This approach addresses the lead connection challenge in combined CRT and CSP systems.

Conclusions:

  • Upgrading to CRT with CSP by utilizing atrial ports for HBP and LBBAP leads is a viable strategy.
  • This method offers a simple and effective solution for patients with severe heart failure.
  • CSP combined with CRT may enhance treatment efficacy compared to CRT alone.

Related Concept Videos

Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
9.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
1.0K